Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion

Pre-exposure prophylaxis with Evusheld, combined with aggressive outpatient treatment, may reduce COVID-19 severity in patients with immune-mediated inflammatory disease on B-cell depletion, according to a letter published in RMB Open. “It is well-known that this group of patients is at very high risk for severe COVID and death, even when fully vaccinated, and it has become clear that more

Read the full article here

Related Articles